Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
Financials
Financial year 2025
PHARMAPULSE from Lasne, company number BE1008309951, closed financial year 2025 with a result of € -6,479 after tax. For that financial year PHARMAPULSE recorded a gross margin of € 889,809 and equity of € -2,362. Compared with financial year 2024, the result moved from € 3,117 to € -6,479. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 22, 2026.
€ -2,362
▼ € 6,479 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6,479
▼ still € 3,117 profit in 2024
Profit after tax over the fiscal year.
€ 55,038
▲ € 46,128 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -3,362.
People and assets in 2025
€ 891,601
▲ € 846,871 vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 23,637
▲ 185% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 260,928
▲ € 237,619 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 49,235 | € 889,809 | ▲ € 840,574 |
| Profit after taxes | € 3,117 | € -6,479 | ▼ € 9,595 |
| Equity | € 4,117 | € -2,362 | ▼ € 6,479 |
| Total debts | € 36,608 | € 284,565 | ▲ € 247,958 |
| Cash | € 8,909 | € 55,038 | ▲ € 46,128 |
| Retained profit | € 3,117 | € -3,362 | ▼ € 6,479 |
| Balance sheet total | € 40,724 | € 282,204 | ▲ € 241,479 |
Key figures of PHARMAPULSE, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMAPULSE?
What happened at PHARMAPULSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6,479 (▼ € 9,595 vs 2024). filed late Source: NBB ↗
- New establishment in Genappe. KBO
- Start of the company according to the CBE. KBO
- PAUL RANSART became a director. NBB
In short
From € 3,117 profit in 2024 to € 6,479 loss in 2025.
Paid € 5,401 in corporate taxes since 2024.
Best year ever: 2024, with € 3,117 profit.
A new publication or filing at PHARMAPULSE? We notify you, reason included.
Follow PHARMAPULSEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMAPULSE is PAUL RANSART. PAUL RANSART is also behind COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS and IMMOLENANS.
Directors
According to the 2025 annual accounts
PAUL RANSART
Manager
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, LENANS, IMMOLENANS, APOGREZ, ANCIAUX, LES PHARMACIES RURALES +15 more
since 2024
Establishments
Establishment units
Physical locations of this company
Rue de la Bachée 86
1380 Lasne
Rue des Lilas 1
1470 Genappe
Active since 11 April 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1008.309.951
- VAT number
- BE 1008.309.951
- Registered office
- Rue de la Bachée 86, 1380 Lasne
- Names & denominations
- PHARMAPULSE
- Enterprise type
- Rechtspersoon
- Legal form
- General partnership
- Legal situation
- Normale toestand
- Start date
- 11 April 2024
- Peppol
- Active · Active since 23 Sept 2025
- Activities · NACE
Activiteiten van uitzendbureaus en andere diensten in verband met personeelsvoorziening
Andere vormen van arbeidsbemiddeling
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Overige zakelijke dienstverlening, neg
Diverse administratieve activiteiten ten behoeve van kantoren